Reply to phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma.
Division of Clinical Oncology, National Cancer Institute, Rio de Janeiro, Brazil.
Luis
L
Olivatto
Carlos Gil
CG
Ferreira
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001005:Anus Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans